Novo Nordisk is reducing prices for its obesity drugs Wegovy and Ozempic. The company announced lower monthly cash prices, starting at $199 per month, months before an agreement with the Trump administration requiring price cuts took effect. Patients who pay in cash can take advantage of this new pricing between now and March 31 next year.
Source: https://www.wsj.com/health/pharma/novo-nordisk-cuts-prices-for-obesity-drugs-e6783e84